Busca avançada
Ano de início
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Site-Specific Modification of the Anticancer and Antituberculosis Polyether Salinomycin by Biosynthetic Engineering

Texto completo
Luhavaya, Hanna [1] ; Williams, Simon R. [2] ; Hong, Hui [1] ; de Oliveira, Luciana Gonzaga [3] ; Leadlay, Peter F. [1]
Número total de Autores: 5
Afiliação do(s) autor(es):
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA - England
[2] Univ Cambridge, Univ Chem Lab, Cambridge CB2 1EW - England
[3] Univ Campinas UNICAMP, Dept Organ Chem, BR-13083970 Campinas, SP - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: CHEMBIOCHEM; v. 15, n. 14, p. 2081-2085, SEP 22 2014.
Citações Web of Science: 7

The complex bis-spiroacetal polyether ionophore salinomycin has been identified as a uniquely selective agent against cancer stem cells and is also strikingly effective in an animal model of latent tuberculosis. The basis for these important activities is unknown. We show here that deletion of the salE gene abolishes salinomycin production and yields two new analogues, in both of which the C18=C19 cis double bond is replaced by a hydroxy group stereospecifically located at C19, but which differ from each other in the configuration of the bis-spiroacetal. These results identify SalE as a novel dehydratase and demonstrate that biosynthetic engineering can be used to redirect the reaction cascade of oxidative cyclization to yield new salinomycin analogues for use in mechanism-of-action studies. (AU)

Processo FAPESP: 11/17510-6 - Estudos sobre a biossíntese e biossíntese combinatória do poliéter ionóforo salinomicina
Beneficiário:Luciana Gonzaga de Oliveira
Linha de fomento: Bolsas no Exterior - Novas Fronteiras